These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31504936)

  • 1. Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c.
    Parra S; Heras M; Herrero P; Amigó N; Garcés E; Girona J; Correig X; Canela N; Castro A
    Rheumatology (Oxford); 2020 Mar; 59(3):650-661. PubMed ID: 31504936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
    Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
    Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
    Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
    Noren Hooten N; Mode NA; Kowalik E; Omoniyi V; Zonderman AB; Ezike N; DiNubile MJ; Levinson SL; Evans MK
    J Transl Med; 2023 Mar; 21(1):190. PubMed ID: 36899335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Gelsolin Level in HIV-1-Infected Patients: An Indicator of Disease Severity.
    Sinha KK; Peddada N; Jha PK; Mishra A; Pandey K; Das VN; Ashish ; Das P
    AIDS Res Hum Retroviruses; 2017 Mar; 33(3):254-260. PubMed ID: 27700141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.
    Madda R; Lin SC; Sun WH; Huang SL
    J Microbiol Immunol Infect; 2019 Oct; 52(5):816-826. PubMed ID: 30170966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
    Audley J; Gliniewicz EF; Zarember KA; Hong HS; Wald G; Kuhns DB; Kang E; Malech HL; Suffredini AF; Noveck RJ; Dinubile MJ; Levinson SL; Stossel TP; Gallin JI
    Inflammation; 2021 Feb; 44(1):270-277. PubMed ID: 32886268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelsolin levels in patients with bronchiolitis.
    Hüsrevoğlu-Esen F; Altuner-Torun Y; Karakükçü Ç; Köse S; Şehriyaroğlu A; Kafadar D; Esen A; Köse M
    Turk J Pediatr; 2018; 60(3):286-289. PubMed ID: 30511541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.
    Tydén H; Lood C; Jönsen A; Gullstrand B; Kahn R; Linge P; Kumaraswamy SB; Dahlbäck B; Bengtsson AA
    Arthritis Res Ther; 2019 May; 21(1):110. PubMed ID: 31046824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma gelsolin level and its relationship with the prognosis of patients with severe burns].
    Huang LF; Yao YM; Dong N; He LX; Zhang QH; Yu Y; Sheng ZY
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):148-51. PubMed ID: 23985203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.
    Rovin BH; Song H; Hebert LA; Nadasdy T; Nadasdy G; Birmingham DJ; Yung Yu C; Nagaraja HN
    Kidney Int; 2005 Oct; 68(4):1825-33. PubMed ID: 16164660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients.
    Pinna S; Pasella S; Deiana M; Baralla A; Mannu A; Masala AGE; Pileri PV; Deiana N; Scognamillo F; Pala C; Zinellu A; Carru C; Deiana L
    J Immunol Methods; 2017 Jul; 446():37-46. PubMed ID: 28390925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
    Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
    Lee PS; Sampath K; Karumanchi SA; Tamez H; Bhan I; Isakova T; Gutierrez OM; Wolf M; Chang Y; Stossel TP; Thadhani R
    J Am Soc Nephrol; 2009 May; 20(5):1140-8. PubMed ID: 19389844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
    Liu L; Zhang T; Ye Y; Zhang S; Chen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
    Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
    Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.